Skip to main content

FDA recall, , Moderate risk

Boston Scientific Coyote Over-the-Wire PTA Balloon Dilation Catheters

The Coyote balloon catheter may not inflate or deflate properly during use.

What happened

Boston Scientific Corporation is removing certain batches of its Coyote Over-the-Wire (OTW) Percutaneous Transluminal Angioplasty (PTA) Balloon Dilatation Catheter devices because of the potential for inflation/deflation difficulty during use in the peripheral vasculature. The company's internal investigation found that a manufacturing process variation resulted in catheters that may not properly inflate or deflate.

The recall affects 21 units distributed nationwide in the states of California, Florida, Illinois, Massachusetts, Minnesota, New York, Ohio, Texas, Virginia and West Virginia. The company began the removal on December 3, 2025, and the FDA added it to its Enforcement Report on January 9, 2026. The affected products include the 2.5mm x120mm, 150 cm catheter, model REF H74939186251210, and the 3.5mm x120mm, 150 cm catheter, model REF H74939186351210.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Boston Scientific Coyote Over-the-Wire PTA Balloon Dilation Catheter

    Model number
    • REF H74939186251210
    • REF H74939186351210
    UDI-DI
    • 08714729796527
    • 37370117
    • 08714729796756
    • 37416646

From the FDA notice

Boston Scientific Coyote OVER-THE-WIRE PTA Balloon Dilation Catheter, 4F, 1) 2.5mm x120mm, 150 cm, UPM/Model No. REF H74939186251210; 2) 3.5mm x120mm, 150 cm, UPM/Model No. REF H74939186351210; Catheter, Angioplasty, Peripheral, Transluminal

Recall details

Company began the recall
Sold in

US Nationwide distribution in the states of Massachusetts, West Virginia, Ohio, California, Minnesota, New York, Virginia, Illinois Texas, Florida, Illinois.

Company
Boston Scientific CorporationMaple Grove, Minnesota
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98149
Recall number
Z-1042-2026
Quantity recalled
21 units

All recalls from Boston Scientific Corporation

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)